NEOPLASMS, HEAD AND NECK
Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, HEAD AND NECK trials appear
Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in reducing head and neck cancer recurrence
Disease control CompletedThis phase 2 trial tested whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard surgery, radiation, and chemotherapy could help prevent head and neck cancer from coming back. The study enrolled 67 adults with advanced, surgically removable head and neck squam…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Experimental combo targets HPV-Driven head and neck tumors
Disease control CompletedThis Phase 2 trial tested a combination of two immunotherapies—PDS0101 and pembrolizumab (Keytruda)—in 95 adults with HPV16-positive head and neck cancer that had returned or spread. The goal was to see if the combo could shrink tumors or slow the disease. Participants received b…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC